Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease

Overview

Journal Mov Disord

Date 2021 Jan 20

PMID 33470460

Citations 35

Authors

Erin K Donahue

Amjad Murdos

Michael W Jakowec

Nasim Sheikh-Bahaei

Arthur W Toga

Giselle M Petzinger

Farshid Sepehrband

Affiliations

Soon will be listed here.

Abstract

Background: The glymphatic system, including the perivascular space (PVS), plays a critical role in brain homeostasis. Although mounting evidence from Alzheimer's disease has supported the potential role of PVS in neurodegenerative disorders, its contribution in Parkinson's disease (PD) has not been fully elucidated. Although idiopathic (IPD) and familial PD (FPD) share similar pathophysiology in terms of protein aggregation, the differential impact of PVS on PD subtypes remains unknown. Our objective was to examine the differences in PVS volume fraction in IPD and FPD compared to healthy controls (HCs) and nonmanifest carriers (NMCs).

Methods: A total of 470 individuals were analyzed from the Parkinson's Progression Markers Initiative database, including (1) IPD (n = 179), (2) FPD (LRRK2 [leucine-rich repeat kinase 2], glucocerebrosidase, or α-synuclein) (n = 67), (3) NMC (n = 101), and (4) HCs (n = 84). Total PVS volume fraction (%) was compared using parcellation and quantitation within greater white matter volume at global and regional levels in all cortical and subcortical white matter.

Results: There was a significant increase in global and regional PVS volume fraction in PD versus non-PD, particularly in FPD versus NMC and LRRK2 FPD versus NMC. Regionally, FPD and NMC differed in the medial orbitofrontal region, as did LRRK2 FPD versus NMC. Non-PD and PD differed in the medial orbitofrontal region and the banks of the superior temporal regions. IPD and FPD differed in the cuneus and lateral occipital regions.

Conclusions: Our findings support the role of PVS in PD and highlight a potentially significant contribution of PVS to the pathophysiology of FPD, particularly LRRK2. © 2021 International Parkinson and Movement Disorder Society.

Citing Articles

Enlarged perivascular spaces under the dorso-lateral prefrontal cortex and severity of autism.

Sotgiu S, Cavassa V, Puci M, Sotgiu M, Turilli D, Jacono A Sci Rep. 2025; 15(1):8142.

PMID: 40059247 PMC: 11891330. DOI: 10.1038/s41598-025-92913-w.

Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.

Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q J Neurol. 2025; 272(3):196.

PMID: 39932513 DOI: 10.1007/s00415-025-12944-1.

Perivascular space imaging during therapy for medulloblastoma.

Song R, Glass J, Wu S, Li Y, Robinson G, Gajjar A PLoS One. 2025; 20(2):e0318278.

PMID: 39919146 PMC: 11805390. DOI: 10.1371/journal.pone.0318278.

Increased burden of enlarged perivascular spaces in patients with patent foramen ovale.

Liu Y, Li Y, Shang Q, Cao J, Zhao W, Xin J Neuroradiology. 2024; 67(1):57-64.

PMID: 39714481 DOI: 10.1007/s00234-024-03532-7.

Effects of one-night partial sleep deprivation on perivascular space volume fraction: Findings from the Stockholm Sleepy Brain Study.

Custer R, Lynch K, Barisano G, Herting M, Akerstedt T, Nilsonne G bioRxiv. 2024; .

PMID: 39484474 PMC: 11527350. DOI: 10.1101/2024.10.26.620382.

References

Asgari M, de Zelicourt D, Kurtcuoglu V . How astrocyte networks may contribute to cerebral metabolite clearance. Sci Rep. 2015; 5:15024. PMC: 4604494. DOI: 10.1038/srep15024. View

Anheim M, Elbaz A, Lesage S, Durr A, Condroyer C, Viallet F . Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology. 2012; 78(6):417-20. DOI: 10.1212/WNL.0b013e318245f476. View

Hoshi A, Tsunoda A, Tada M, Nishizawa M, Ugawa Y, Kakita A . Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease. Brain Pathol. 2016; 27(2):160-168. PMC: 8028881. DOI: 10.1111/bpa.12369. View

Healy D, Falchi M, OSullivan S, Bonifati V, Durr A, Bressman S . Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol. 2008; 7(7):583-90. PMC: 2832754. DOI: 10.1016/S1474-4422(08)70117-0. View

Boland B, Yu W, Corti O, Mollereau B, Henriques A, Bezard E . Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018; 17(9):660-688. PMC: 6456907. DOI: 10.1038/nrd.2018.109. View

Trinh J, Amouri R, Duda J, Morley J, Read M, Donald A . Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism. Neurobiol Aging. 2013; 35(5):1125-31. DOI: 10.1016/j.neurobiolaging.2013.11.015. View

Henderson M, Trojanowski J, Lee V . α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies. Neurosci Lett. 2019; 709:134316. PMC: 7014913. DOI: 10.1016/j.neulet.2019.134316. View

Dinov I, Van Horn J, Lozev K, Magsipoc R, Petrosyan P, Liu Z . Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline. Front Neuroinform. 2009; 3:22. PMC: 2718780. DOI: 10.3389/neuro.11.022.2009. View

Wen M, Xu Z, Lu Z, Chan L, Tan E, Tan L . Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease. Sci Rep. 2017; 7(1):12559. PMC: 5624890. DOI: 10.1038/s41598-017-12947-7. View

10.

van der Vegt J, Hulme O, Zittel S, Madsen K, Weiss M, Buhmann C . Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease. Brain. 2013; 136(Pt 4):1192-203. DOI: 10.1093/brain/awt027. View

11.

Jessen N, Munk A, Lundgaard I, Nedergaard M . The Glymphatic System: A Beginner's Guide. Neurochem Res. 2015; 40(12):2583-99. PMC: 4636982. DOI: 10.1007/s11064-015-1581-6. View

12.

Zhang J, Yang B, Sun H, Zhou Y, Liu M, Ding J . Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease. Neurosci Lett. 2016; 614:7-15. DOI: 10.1016/j.neulet.2015.12.057. View

13.

Debette S, Schilling S, Duperron M, Larsson S, Markus H . Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis. JAMA Neurol. 2018; 76(1):81-94. PMC: 6439887. DOI: 10.1001/jamaneurol.2018.3122. View

14.

Sled J, Zijdenbos A, Evans A . A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998; 17(1):87-97. DOI: 10.1109/42.668698. View

15.

Schiesling C, Kieper N, Seidel K, Kruger R . Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol Appl Neurobiol. 2008; 34(3):255-71. DOI: 10.1111/j.1365-2990.2008.00952.x. View

16.

Yao M, Herve D, Jouvent E, Duering M, Reyes S, Godin O . Dilated perivascular spaces in small-vessel disease: a study in CADASIL. Cerebrovasc Dis. 2014; 37(3):155-63. DOI: 10.1159/000356982. View

17.

Moon S, Dinov I, Kim J, Zamanyan A, Hobel S, Thompson P . Structural Neuroimaging Genetics Interactions in Alzheimer's Disease. J Alzheimers Dis. 2015; 48(4):1051-63. PMC: 4730943. DOI: 10.3233/JAD-150335. View

18.

Zhu Y, Dufouil C, Soumare A, Mazoyer B, Chabriat H, Tzourio C . High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J Alzheimers Dis. 2010; 22(2):663-72. DOI: 10.3233/JAD-2010-100378. View

19.

Kim Y, Jeong H, Song I, Chung Y, Namgung E, Kim Y . Brain perfusion alterations in depressed patients with Parkinson's disease. Ann Nucl Med. 2016; 30(10):731-737. DOI: 10.1007/s12149-016-1119-2. View

20.

Zong X, Park S, Shen D, Lin W . Visualization of perivascular spaces in the human brain at 7T: sequence optimization and morphology characterization. Neuroimage. 2015; 125:895-902. DOI: 10.1016/j.neuroimage.2015.10.078. View